BNB PLUS CORP (BNBX) Stock Fundamental Analysis

NASDAQ:BNBX • US03815U6073

0.6813 USD
-0.02 (-3.36%)
At close: Mar 2, 2026
0.7 USD
+0.02 (+2.74%)
After Hours: 3/2/2026, 8:04:52 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BNBX. BNBX was compared to 57 industry peers in the Life Sciences Tools & Services industry. BNBX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BNBX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year BNBX has reported negative net income.
  • In the past year BNBX has reported a negative cash flow from operations.
  • In the past 5 years BNBX always reported negative net income.
  • In the past 5 years BNBX always reported negative operating cash flow.
BNBX Yearly Net Income VS EBIT VS OCF VS FCFBNBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • The Return On Assets of BNBX (-1565.95%) is worse than 96.49% of its industry peers.
  • Looking at the Return On Equity, with a value of -3014.91%, BNBX is doing worse than 91.23% of the companies in the same industry.
Industry RankSector Rank
ROA -1565.95%
ROE -3014.91%
ROIC N/A
ROA(3y)-565.1%
ROA(5y)-366.41%
ROE(3y)-1098.28%
ROE(5y)-697.65%
ROIC(3y)N/A
ROIC(5y)N/A
BNBX Yearly ROA, ROE, ROICBNBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K -1K -2K -3K

1.3 Margins

  • BNBX has a Gross Margin of 33.24%. This is in the lower half of the industry: BNBX underperforms 66.67% of its industry peers.
  • In the last couple of years the Gross Margin of BNBX has declined.
  • BNBX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.17%
GM growth 5Y-8.93%
BNBX Yearly Profit, Operating, Gross MarginsBNBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • BNBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BNBX has been increased compared to 1 year ago.
  • BNBX has more shares outstanding than it did 5 years ago.
  • BNBX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BNBX Yearly Shares OutstandingBNBX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M
BNBX Yearly Total Debt VS Total AssetsBNBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -130.20, we must say that BNBX is in the distress zone and has some risk of bankruptcy.
  • BNBX has a Altman-Z score of -130.20. This is amonst the worse of the industry: BNBX underperforms 85.96% of its industry peers.
  • BNBX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -130.2
ROIC/WACCN/A
WACC10.72%
BNBX Yearly LT Debt VS Equity VS FCFBNBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M -15M

2.3 Liquidity

  • A Current Ratio of 0.91 indicates that BNBX may have some problems paying its short term obligations.
  • The Current ratio of BNBX (0.91) is worse than 87.72% of its industry peers.
  • BNBX has a Quick Ratio of 0.91. This is a bad value and indicates that BNBX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BNBX has a Quick ratio of 0.87. This is amonst the worse of the industry: BNBX underperforms 82.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.87
BNBX Yearly Current Assets VS Current LiabilitesBNBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 84.27% over the past year.
  • BNBX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.79%.
  • Measured over the past years, BNBX shows a small growth in Revenue. The Revenue has been growing by 2.04% on average per year.
EPS 1Y (TTM)84.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.32%
Revenue 1Y (TTM)-21.79%
Revenue growth 3Y-51.01%
Revenue growth 5Y2.04%
Sales Q2Q%-75.48%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y77.08%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year40%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BNBX Yearly Revenue VS EstimatesBNBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
BNBX Yearly EPS VS EstimatesBNBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -100K -200K -300K

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • BNBX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year BNBX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BNBX Price Earnings VS Forward Price EarningsBNBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BNBX Per share dataBNBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for BNBX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BNB PLUS CORP

NASDAQ:BNBX (3/2/2026, 8:04:52 PM)

After market: 0.7 +0.02 (+2.74%)

0.6813

-0.02 (-3.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-11
Earnings (Next)05-13
Inst Owners0.99%
Inst Owner ChangeN/A
Ins Owners4.64%
Ins Owner Change59.88%
Market Cap2.98M
Revenue(TTM)2.68M
Net Income(TTM)-69.49M
Analysts43.33
Price TargetN/A
Short Float %1.71%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-82.3%
Min Revenue beat(2)-87.98%
Max Revenue beat(2)-76.62%
Revenue beat(4)1
Avg Revenue beat(4)-42.54%
Min Revenue beat(4)-87.98%
Max Revenue beat(4)13.1%
Revenue beat(8)2
Avg Revenue beat(8)-25.08%
Revenue beat(12)5
Avg Revenue beat(12)-17.71%
Revenue beat(16)8
Avg Revenue beat(16)-10.94%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.11
P/FCF N/A
P/OCF N/A
P/B 1.29
P/tB 1.29
EV/EBITDA N/A
EPS(TTM)-685.76
EYN/A
EPS(NY)-84.15
Fwd EYN/A
FCF(TTM)-2.94
FCFYN/A
OCF(TTM)-2.86
OCFYN/A
SpS0.61
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1565.95%
ROE -3014.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.24%
FCFM N/A
ROA(3y)-565.1%
ROA(5y)-366.41%
ROE(3y)-1098.28%
ROE(5y)-697.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.17%
GM growth 5Y-8.93%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 81.49%
Cap/Sales 11.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.87
Altman-Z -130.2
F-Score4
WACC10.72%
ROIC/WACCN/A
Cap/Depr(3y)74.6%
Cap/Depr(5y)112.72%
Cap/Sales(3y)14.16%
Cap/Sales(5y)14.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.32%
EPS Next Y77.08%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.79%
Revenue growth 3Y-51.01%
Revenue growth 5Y2.04%
Sales Q2Q%-75.48%
Revenue Next Year40%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.7%
OCF growth 3YN/A
OCF growth 5YN/A

BNB PLUS CORP / BNBX FAQ

Can you provide the ChartMill fundamental rating for BNB PLUS CORP?

ChartMill assigns a fundamental rating of 1 / 10 to BNBX.


What is the valuation status for BNBX stock?

ChartMill assigns a valuation rating of 0 / 10 to BNB PLUS CORP (BNBX). This can be considered as Overvalued.


What is the profitability of BNBX stock?

BNB PLUS CORP (BNBX) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for BNBX stock?

The Earnings per Share (EPS) of BNB PLUS CORP (BNBX) is expected to grow by 77.08% in the next year.